跳至主要内容
临床试验/NL-OMON31923
NL-OMON31923已完成不适用

Acute and chronic inflammatory responses induced by smoking in individuals being susceptible and non-susceptible for development of COPD: from specific disease phenotyping towards novel made therapy (study 1). - Acute smoking in COPD

niversitair Medisch Centrum Groningen0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age 18-75 years
  • Age, pack years, FEV1/FVC and FEV1% predicted must fit in one of the 5 groups of table 4.1
  • Able to stop smoking for 10 days and start smoking 3-4 cigarettes within 1 hour
  • Physically and mentally able to undergo the total study protocol
  • Written informed consent

排除标准

  • Participation in another study
  • Alpha-1-antitrypsin deficiency
  • Selected grade 1-3 co-morbidity listed in the ACE-27
  • Active pulmonary infection like tuberculosis, pneumonia, flue, tracheobronchitis
  • Active extra-pulmonary infection like hepatitis A-C, cystitis, gastro-enteritis etc
  • Pulmonary diseases like sarcoidosis, IPF, silicosis, hypersensitivity pneumonitis
  • Life threatening diseases like carcinoma, AIDS (including HIV+), acute leukaemia etc
  • Medication that may affect the results of the study: NSAID*s, immunosuppressive agents like prednisolon, metotrexate, azathioprine,Sintrom tablets

研究者

相似试验